Exploring BAFF: its expression, receptors and contribution to the immunopathogenesis of Sjögren's syndrome.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 26790457.
- Also identified by DOI 10.1093/rheumatology/kev420.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
SS is an autoimmune condition characterized by exocrine gland destruction, autoantibody production, immune complex deposition and systemic complications associated with lymphocytic infiltration of many organs. Genetic, environmental and viral factors play a role in disease aetiology, however, the exact mechanisms driving the immunopathogenesis of SS remain uncertain. Here we discuss a role for B cell activating factor (BAFF), whereby B cell hyperactivity and increased BAFF secretion observed in patients and animal models of the disease can be explained by the altered expression of cell-specific BAFF/BAFF receptor (BAFF-R) variants in several immune cell types. Understanding the role of BAFF/BAFF-R heterogeneity in SS pathogenesis could help to facilitate new treatment strategies for patients.
Medical subject headings
- B-Cell Activating Factor
- B-Cell Activation Factor Receptor
- Sjogren's Syndrome